✦ LIBER ✦

Inhibition of α-synuclein Aggregation Leads to Therapeutic Benefits in Multiple Animal Models of Parkinson'S Disease.

✍ Scribed by Hung, Lin W.; Villemange, Victor L.; Sherratt, Nicki; George, Jessica; Lim, SinChun; Masters, Colin L.; Cappai, Roberto; Cherny, Robert; White, Anthony R.; Donnelly, Paul S.; Finkelstein, David I.; Barnham, Kevin J.

Book ID: 123300045
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 63 KB
Volume: 6
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2010.08.192

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of α-synuclein in Parkinson's d

The role of α-synuclein in Parkinson's disease: insights from animal models

✍ Maries, Eleonora; Dass, Biplob; Collier, Timothy J.; Kordower, Jeffrey H.; Steec 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 382 KB

Statins reduce neuronal α-synuclein aggr

Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease

✍ Pazit Bar-On; Leslie Crews; Andrew O. Koob; Hideya Mizuno; Anthony Adame; Brian 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 885 KB

Inhibition of formation of α-synuclein i

Inhibition of formation of α-synuclein inclusions by mannosylglycerate in a yeast model of Parkinson's disease

✍ Faria, Cristiana; Jorge, Carla D.; Borges, Nuno; Tenreiro, Sandra; Outeiro, Tiag 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 647 KB

Rescuing Defective Vesicular Trafficking

Rescuing Defective Vesicular Trafficking Protects against α-Synuclein Toxicity in Cellular and Animal Models of Parkinson’s Disease

✍ Lashuel, Hilal A.; Hirling, Harald 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 473 KB

Differential inhibition of α-synuclein o

Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract

✍ Ronit Shaltiel-Karyo; Dan Davidi; Moran Frenkel-Pinter; Michael Ovadia; Daniel S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 789 KB

Pharmacological inhibition of PARP-1 red

Pharmacological inhibition of PARP-1 reduces α-synuclein- and MPP+-induced cytotoxicity in Parkinson’s disease in vitro models

✍ Tiago Fleming Outeiro; Tom N. Grammatopoulos; Steven Altmann; Allison Amore; Dav 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 441 KB